Archive for the Category ◊ Market ◊

• Tuesday, February 04th, 2014

Bard Announces $500 Million Share Repurchase Authorization MURRAY HILL, N.J.–(BUSINESS WIRE)–C. R. Bard, Inc. (NYSE:BCR) today announced that its Board of Directors has authorized the repurchase of up to $500 million of the company’s common stock. This new authorization is in addition to the approximately $55 million remaining under the Company’s prior authorization. Share repurchases […]

• Wednesday, December 11th, 2013

Israeli medtech company Lumenis files for an initial public offering worth $115 million. Lumenis Ltd., an Israeli medtech company that makes lasers used in eye surgery, urology and cosmetic medical procedures, filed today for an initial public offering worth $115 million. Yokneam, Israel-based Lumenis said it plans to trade on the NASDAQ stock exchange under […]

• Tuesday, November 26th, 2013

Pixium Vision raises €15 million led by Sofinnova Partners PARIS, November 25, 2013 /PRNewswire/ — Funds to advance development of retinal implant systems that aim to restore vision in blind people Financing includes Bpifrance, through the InnoBio fund Pixium Vision (“Pixium”), a developer of innovative retinal implant systems that aim to restore vision in the […]

• Thursday, November 21st, 2013

Minnesota medical device maker Cardiovascular Systems plans to offer more than 2.1 million shares of its common stock, a potential take of $70 million based on the company’s estimates. Cardiovascular Systems (NSDQ:CSII) announced this week an upcoming stock offering worth up to $70 million in net proceeds, according to an early estimate. The device maker has yet […]

• Friday, November 15th, 2013

Cook Medical promotes Pete Yonkman to president of the Cook Group’s medical subsidiaries, with Hawking remaining president of Cook Group. Cook Medical said it named Pete Yonkman as president, with Kem Hawkins stepping down from the role to better oversee Cook Group altogether. Yonkman has been with Cook Medical for the past 12 years, originally […]

• Thursday, November 14th, 2013

ConMed responds to a challenge from activist investor group Voce Capital Management, citing “the strong operating performance delivered by ConMed over the past several years.” ConMed (NSDQ:CNMD) today responded to a long and critical letter from Voce Capital Management issued last week that demanded steps toward a strategic exit and the end “a culture of nepotism, […]

• Wednesday, November 13th, 2013

Solta Medical Inc. SLTM +1.27% unveiled restructuring plans to improve its financial performance, and has hired an advisor to help evaluate strategic alternatives, including a possible sale or merger of the medical aesthetics device maker. Investors cheered the news, sending shares up 17% to $2.15 in after-hours trading. Solta Medical’s restructuring plan, which includes a reduction in work […]

• Wednesday, November 13th, 2013

IRVINE, CA–(Marketwired – November 11, 2013) – BIOLASE, Inc. (NASDAQ: BIOL), the world’s leading manufacturer and distributor of dental lasers, and a pioneer in laser surgery in other medical specialties, today announced that its Board of Directors (“Board”) has authorized BIOLASE to seek the services of an investment bank to explore possible M&A transactions with the […]

• Tuesday, November 12th, 2013

Sensible Medical Innovations Ltd., which has developed a non-invasive thoracic fluid status monitor, has closed a financing round led by Boston Scientific Corporation (NYSE: BSX). Sources inform ”Globes” that the company raised $20 million. The company declined to confirm the amount. The company will use the proceeds to obtain additional clinical data and commercialize the […]

• Monday, November 11th, 2013

California’s Tandem Diabetes plans to offer more than 8.2 million shares of stock at a maximum of $15 apiece for an initial public offering of up to $123.2 million. Tandem Diabetes Care upped the ante on its venture-backed initial public offering, increasing its maximum aggregate price to $123.2 million and pricing shares at between $13-$15 […]